1. Clinical trial monitoring with Bayesian hypothesis testingJohn D. CookValen E. Johnson August 6, 2008 2. Estimation and Testing Bayesians typically approach a clinical…

Slide 1CHEMOTHERAPY IN ADVANCED NSCLC If you have a long-distance patient with an advanced NSCLC, think it over before to treat him with chemotherapy......... HANSEN, personal…

1.Advances in the treatment of T cell lymphomas Yok-Lam Kwong Department of Medicine Queen Mary Hospital 2. Mature T and NK cell malignancies T-cell prolymphocytic leukaemia…

Abstract:148 Frontline Therapy with the RiBVD Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final…

Slide 1 Advances in the Management of Relapsed/Refractory Multiple Myeloma Robert Z. Orlowski, Ph.D., M.D. Director, Myeloma Section Florence Maude Thomas Cancer Research…

Slide 1 Have the OPTIMOX-2, CAIRO-3, COIN, DREAM and other recent trials settled the question of maintenance versus observation in advanced CRC? Yes Deborah Schrag, MD, MPH…

Slide 1 FORECLOSURE PREVENTION AND LOSS MITIGATION OVERVIEW FEBRUARY 24, 2011 FAITH-BASED AND NEIGHBORHOOD PARTNERS FORECLOSURE PREVENTION EDUCATION WORKSHOP 1 Slide 2 Today’s…

Slide 1 Slide 2 Surviving GIST: Connecting the Dots Life Fest 2006 Norman Scherzer & Jerry Call Slide 3 Disclaimer!  Jerry Call and Norman Scherzer are not physicians…

Slide 1 Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC Beth Eaby-Sandy, MSN, CRNP, OCN ® Nurse Practitioner Abramson Cancer Center…

Slide 1 Summary 2011 Founded 2010 in Houston Vision: To be the leader in the development of metronomic therapies for cancer $4.2M Series A: Founded by seasoned biotech, pharma…